Dupilumab for EoE: How Is it Improving Treatment?
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.
Source: medscape.com
Abandon Current News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abandon Current. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abandon Current Today - Breaking & Trending Today